MARKET

FLHLF

FLHLF

Filament Health
OTCMQB

Real-time Quotes | Nasdaq Last Sale

0.089
-0.030
-25.01%
Closed 14:19 08/10 EDT
OPEN
0.100
PREV CLOSE
0.119
HIGH
0.100
LOW
0.089
VOLUME
20.00K
TURNOVER
1.89K
52 WEEK HIGH
0.368
52 WEEK LOW
0.081
MARKET CAP
14.70M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
Canada-Based Venture Project Solace Aims To Provide Access And Data On Medical Psilocybin
TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace.
Benzinga · 07/28 14:04
FILAMENT HEALTH ANNOUNCES PARTICIPATION IN PROJECT SOLACE
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced its participation in Project Solace, the world's largest medical psilocybin access and d...
CNW Group · 07/28 11:30
BRIEF-Filament Health Reports Closing Of $2,500,080 Private Placement
BRIEF-Filament Health Reports Closing Of $2,500,080 Private Placement
Reuters · 07/13 20:07
FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, is pleased to announce that, further to its news release dated June 30, 2022, the Company has completed ...
CNW Group · 07/13 20:05
BRIEF-Filament Health Issued Third Patent By United States Patent And Trademark Office
BRIEF-Filament Health Issued Third Patent By United States Patent And Trademark Office
Reuters · 07/12 20:52
FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK OFFICE
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that it has been issued a third patent by the United States Patent and Trademark Office ...
CNW Group · 07/12 20:42
Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs
Clinical-stage natural psychedelics company Filament Health Corp.
Benzinga · 07/08 17:09
Filament Health starts dosing in its FDA-approved psilocin clinical trial
Filament Health (OTC:FLHLF) on Thursday <a href="https://seekingalpha.com/pr/18858976-filament-healt...
Seekingalpha · 07/07 21:16
More
No Data
Learn about the latest financial forecast of FLHLF. Analyze the recent business situations of Filament Health through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average FLHLF stock price target is 1.174 with a high estimate of 1.174 and a low estimate of 1.174.
High1.174
Average1.174
Low1.174
Current 0.0892
EPS
Actual
Estimate
-0.01-0.01-0.00-0.00
Q4 2021
Q1 2022
Q2 2022
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
No Data
About FLHLF
Filament Health Corp. is a Canada-based natural psychedelic drug discovery and development company. The Company is engaged in natural extraction technologies utilizing patented and patent-pending processes to manufacture pharmaceutical grade psychoactive products. The Company operates through its Health Canada Dealer's license at its good manufacturing practice (GMP) drug discovery and manufacturing facility. The Company's wholly owned subsidiary includes Psilo Scientific Ltd. (Psilo). Psilo is a drug discovery and extraction technologies company.

Webull offers kinds of Filament Health Corp stock information, including OTCMQB:FLHLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLHLF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FLHLF stock methods without spending real money on the virtual paper trading platform.